Podcasts about Artificial pancreas

This week on The Naked Scientists: Scientists invent artificial platelets to help clot blood; why it might be time to reappraise the peace-loving nature of bonobos; and why the Moon may have turned itself inside out in the past... Like this podcast? Please help us by supporting the Naked Scientists

The Smart 7 is an award winning daily podcast that gives you everything you need to know in 7 minutes, at 7 am, 7 days a week...With over 15 million downloads and consistently charting, including as No. 1 News Podcast on Spotify, we're a trusted source for people every day and the Sunday 7 won a Gold Award as “Best Conversation Starter” in the International Signal Podcast Awards If you're enjoying it, please follow, share, or even post a review, it all helps...Today's episode includes the following guests:GuestsDr Vivek Murthy - US Surgeon General Will Guyatt - The Smart 7's Tech Guru Lee Watson - Type 1 Diabetes patient testing the Artificial PancreasAnge Abbott - Type 1 Diabetes patient testing the Artificial PancreasProfessor Brian Cox - Royal Society Professor for Public Engagement in ScienceDr Vanessa Raymont - Neuroscientist at Oxford University Dr Adam Staffaroni - Clinical Neuropsychologist and Associate Professor at the University of California in San Francisco Kelly Salisbury - Primate Keeper at Twycross Contact us over at X or visit www.thesmart7.comPresented by Ciara Revins, written by Liam Thompson and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.

California introduces a bill that would allow employees to possibly relax … Amazon just walked out on its self-checkout technology … and England's NHS will provide an artificial pancreas to thousands of diabetes patients. It's Wednesday, April 3rd and this is Engadget News. Learn more about your ad choices. Visit megaphone.fm/adchoices

Thousands with Type 1 diabetes in England are to receive an 'artificial pancreas' in a world-first initiative being rolled out by the NHS.TikTok launches a new feed dedicated to STEM - science, technology, engineering and mathematics - to engage young people in the fields. Google set to delete billions of records from Incognito tracking.Also in this episode:Truth Social: Trump's DJT stock plummets a week after going publicStudy aims to break link between brain injury and depressionPolice to search deleted social media of woman accused of mushroom poisoning deathsProtein found in water bears is shown to slow down human ageingWhy scientists say seagulls deserve more creditFollow us on X or on Threads. Hosted on Acast. See acast.com/privacy for more information.

Host: Stuart Weinzimer, MD The artificial pancreas represents the integration of two separate devices: a continuous glucose monitor and an insulin pump. Learn more about this technology and how it can help improve diabetic patients' quality of life with Dr. Stuart Weinzimer, Interim Section Chief of Pediatric Endocrinology and Diabetes at Yale School of Medicine.

Dr. Marc Breton and Dr. Boris Kovatchev both knew they wanted to pursue a career in STEM research from an early age. Dr. Kovatchev was inspired to apply his statistical and mathematical prowess to diabetes after his father was diagnosed with the condition. It took over 40 factors but he was able to describe the body's insulin system mathematically. Dr Breton came to the world of biotechnological engineering from the world of rocketry. In this episode, they talk about their remarkable invention, a device that regulates insulin for diabetics much like a human pancreas. Plus, they bring special guest, UVA third-year student, Benjamin Motta, who joined the clinical trial for their artificial pancreas at age 12.

Good News: An amazing development in medical technology may bring new hope to people suffering from Type 1 Diabetes, Link HERE The Good Word: A truly brilliant quote from the Rev. Dr. Martin Luther King Jr. Good To Know: A fascinating fact about the oceans of the earth! Good News: Miniature wetlands are a part […]

Join Sammar Ahmad, Jalees Ahmed and Daniyal Ahmad for Tuesday's show where we will be discussing: International Day of Education / The Brain / Artificial Pancreas News and Weather updates Segment 1 - Celebrating International Day of Education Segment 2 - Remarkable discovery of an entire new layer of brain tissue Segment 3 - Artificial pancreas for diabetic patients: Is this the way forward?

Arecor Therapeutics (AIM:AREC) CEO Sarah Howell & scientist Rafic Sukar visited the Proactive London studio on World Diabetes Day to provide an update on the work they're doing to make life easier for those suffering with the disease. Sukar was diagnosed with type 1 diabetes as an infant and now works on developing new treatments. The pair explains some of the challenges that diabetics face each day in managing the condition, and reveal their predictions for when a fully closed loop artificial pancreas system will be available to patients. #ProactiveInvestors #Arecor #InsertStockMarket #biotech #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

The latest sleep apnea treatment, an artificial pancreas that uses AI and the promising new hair loss remedy.See omnystudio.com/listener for privacy information.

The latest sleep apnea treatment, an artificial pancreas that uses AI and the promising new hair loss remedy.

Arecor Therapeutics PLC chief executive Sarah Howell speaks to Proactive following the publication of new study data for its lead product AT247, an ultra-rapid-acting form of insulin. Howell suggests that the study indicates that Arecor may have created an insulin that can be absorbed more quickly into the body than any existing rival product. A sufficiently quickly-to-absorb form of insulin has until now been the sole remaining missing component of a useable artificial pancreas system. #proactiveinvestors #arecortherapeutics #diabetes

Welcome back to The Business of Healthcare Podcast.  This week I have the absolute pleasure of speaking with Partha Kar who is a Consultant in Diabetes and Endocrinology at Portsmouth Hospital NHS Trusts.   Partha also holds two other national roles and has over 24 years experience working within the NHS.    This week on the Business of Healthcare  What made Partha choose a career in medicine & has he ever questioned is this career for me?  Slices of luck and what they are  What attracted Partha to working in Diabetes  How can we create change  Favourite Marvel film  Combining Leadership & Management & learning the hard way  Is it essential or desirable criteria ? Always keeping the door open  Artificial Pancreas  Being clear with your time and protecting yourself from burnout  Always clearing the to do list and how Partha manages this  Racism, Sexism & Bias    How to Connect with Partha Kar  LinkedIn  Twitter     Work with me    I'm Tara Humphrey and I'm the founder of THC Primary Care, a leading healthcare consultancy. I provide project and network management to Primary Care Networks and consulting support to clinical leads. To date, I've worked with 11 Training Hubs and supported 19 Primary Care Networks and 3 GP Federations.  I understand and appreciate the complexity of healthcare and what it takes to deliver projects across multiple practices.  I have over 20 years of project management and business development experience across the private and public sector and have an MBA in Leadership and Management in Healthcare. I'm also published in the London Journal of Primary Care and the author of over 250 Blogs    For more weekly insights and advice sign up to my newsletter.  Improving the Business of Healthcare – One Episode at a Time     Thanks for tuning into this week's episode of the Business of Healthcare Podcast. If you enjoyed this episode, head over to Apple Podcasts to subscribe, leave your honest review, and share your favourite episodes on social media. Find us on Twitter, Instagram and LinkedIn or visit our website – THC Primary Care. 

Australia has many stories from people who say they have long COVID but who are unable to access help | Updated versions of coronavirus vaccines targeting the Omicron variant have been announced, yet the virus still mutates | People with Type 1 diabetes need to monitor their blood glucose but automatic systems are being trialled to assist them | A study on the behaviour of teens undertaken during the pandemic identified some of the particular health risks for this group.

People with Type 1 diabetes need to monitor what's going on with their bodies because they can't make insulin—and it's vital in maintaining blood glucose. An imbalance can be dangerous and damage blood vessels, nerves, and kidneys.

Today, in episode 535, our expert Infectious Disease Doctor and Community Health Specialist discuss what you need to know about Public Health. We bring on our producer, Graham Patterson, to talk about how black and brown seniors usually get a less effective vaccines, and how a new artificial pancreas could help those with diabetes. As always, join us for all the Public Health information you need, explained clearly by our health experts. Website: NoiseFilter - Complex health topics explained simply (noisefiltershow.com) Animations: NoiseFilter - YouTube Instagram: NoiseFilter (@noisefiltershow) • Instagram photos and videos Facebook: NoiseFilter Show | Facebook TikTok: https://www.tiktok.com/@noisefiltershow --- Send in a voice message: https://anchor.fm/noisefilter/message

Topic: 01 Artificial pancreas to revolutionise diabetes care in England. Topic: 02 Sport improves concentration and quality of life. Presenters: Murabbi Touqeer Tanvir & Waleed Ahmed Guest Name: 1. Dr. Mark Vanderpump 2. Dr David Hopkins 3. Miss Farah Ahmad 4. Jack Claxton 5. Mark Wadie Researchers: Henna Ahmad, Neha Latif, Qudsiya Ward & Saleha Bakhtiar Producer: Saqib munir Ahmed

Dr. Sanjoy Dutta, PhD, is the Chief Scientific Officer at JDRF International (https://www.jdrf.org/) a nonprofit organization that funds Type 1 Diabetes (T1D) research, provides a broad array of community and activist services to the T1D population, and actively advocates for regulation favorable to medical research and approval of new and improved treatment modalities. Dr. Dutta oversees all of JDRF's efforts to cure Type 1 Diabetes and improve the lives of those living with it, which includes beta cell therapies, immunotherapies, glucose control and related disease complications. He is also responsible for international partnerships with world-leading government, non-government, foundation and commercial organizations. Dr. Dutta joined JDRF in 2009. Prior to coming to JDRF, Dr. Dutta was the Associate Director of Translational Medicine and Clinical Biomarkers at Bristol-Myers Squibb, and Principal Scientist of Cardiovascular and Metabolic Diseases at Hoffmann-La Roche. Dr. Dutta obtained his doctorate from the department of biochemistry and molecular biology at the University of Southern California and was a JDRF Postdoctoral Fellow in the department of cell biology and the Joslin Diabetes Center at Harvard Medical School.

We are looking into the science behind the headlines in the first week of 2022 - including a medical update on omicron and how this variant impacts disease severity, a review of some of the top games and gadgets to look out for in the year ahead, a celebration marking 100 years since the first use of insulin to manage diabetes, and a behind the scenes preview of the new Sir David Attenborough documentary, 'The Green Planet'. Like this podcast? Please help us by supporting the Naked Scientists

We are looking into the science behind the headlines in the first week of 2022 - including a medical update on omicron and how this variant impacts disease severity, a review of some of the top games and gadgets to look out for in the year ahead, a celebration marking 100 years since the first use of insulin to manage diabetes, and a behind the scenes preview of the new Sir David Attenborough documentary, 'The Green Planet'. Like this podcast? Please help us by supporting the Naked Scientists

ResourcesOpen Artificial Pancreas System project (Open APS): www.openaps.orgDiabetes technology resources: www.danatech.orgThe Artificial Pancreas: Where We Are, Where We're Going: https://journals.sagepub.com/doi/full/10.1177/2325160315572249

After building her own DIY “artificial pancreas,” Dana Lewis helped found the open source artificial pancreas movement (known as “OpenAPS”), making safe and effective artificial pancreas technology available (sooner) for people with diabetes around the world. She authored the book, "Automated Insulin Delivery: How artificial pancreas “closed loop” systems can aid you in living with diabetes", to help more people understand automated insulin delivery systems, in addition to a series of children's books such as "Understanding Automated Insulin Delivery: A basic book for kids, family, and friends of people living with diabetes", which is also available as a free animated video. She is currently researching numerous diabetes-related data science and open source artificial pancreas system projects. Bon talks with Dana about why she designed an “artificial pancreas”, patients as the experts, and how we can reduce stigma among people living with chronic diseases.

Dr Sufyan Hussain is a Consultant Diabetes and Endocrine Physician at Guy's and St Thomas Hospital in London, and Honorary Senior Clinical Lecturer at King's College London, as well as a father of three and self-confessed 'granola addict'. Passionate about improving care for diabetes, he has also lived with type 1 diabetes for almost 30 years - offering an incredibly unique perspective on what it means to live with type 1 diabetes from both inside and outside the NHS. Sufyan was 10 years old and living in Karachi in Pakistan when he was diagnosed. In this episode we talk about the honeymoon phase in those early years, his esteemed 20 year career in medicine, and why he chose to work in a field he was so personally tied to. Documenting his own challenges with type 1 diabetes, from new hospitals and night shifts to hypos at the operating table, Sufyan also talks about how these experiences have impacted the support he offers to those in his care. We also discuss disparities in the healthcare system, how the pandemic has impacted the NHS, and his own interest in DIY looping. This is a fascinating episode and I'm very happy Sufyan could share some of his renowned expertise with us, as well as his own personal story.  Follow Sufyan on Twitter. Disclaimer on behalf of Dr Hussain: Dr Sufyan Hussain has not received any financial remuneration or honorarium for this podcast and the sponsors have had no involvement in the recording.

Researchers at Cambridge's Institute of Metabolic Science say the automated portable device, worn externally, can help people living with both type 2 diabetes and kidney failure by more effective reduction of blood sugar levels. You're spending a third of your waking life glued to TV and streaming. How an anti-snoring machine is reducing the need to give Covid patients invasive mechanical ventilation. Child safety alert over cheap, unbranded toys bought online. The Ether cryptocurrency neared two-month high ahead of major blockchain protocol change. Major study finds ageing societies ‘afford more advantages to men than women'. From D-Day spying to keeping tabs on China...UK opens first space command HQ in Buckinghamshire. See acast.com/privacy for privacy and opt-out information.

This episode, Kate and Matt are joined by the lovely Jasmine Schipp. Jasmine is a PhD candidate researching the experiences of people with type 1 diabetes who are using open-source technology to manage their condition. We chat briefly about what diabetes is, the different types of diabetes, the role of the pancreas… and how people are taking matters into their own hands to create artificial pancreases! We then take a deep dive into how this amazing technology, and the current trials and tribulations associated with it, are impacting the people behind the diagnoses. We also tackle a listener question about phantom limbs… what are they, and can they be “cured”? If you liked what Jasmine had to say and want to find more of her, you can find her on Twitter @JasmineSchipp (https://twitter.com/JasmineSchipp). And, as always, you can find us @curiosityrat on twitter, instagram, and facebook, and send your listener questions in to curiosityrat@gmail.com We also now have a Patreon! If you love our content and want to support us you can jump on to https://www.patreon.com/curiosityrat and become a patron. There is absolutely ZERO pressure but if you have as little as $1/month you can chuck it our way to help us out and show you appreciate all the time and effort that goes into making this show. Jasmine's paper: https://www.liebertpub.com/doi/abs/10.1089/dia.2020.0652 Language Statement: https://www.diabetesaustralia.com.au/wp-content/uploads/Language-position-statement-2016.pdf Additional Diabetes Resources: https://www.diabetesaustralia.com.au/about-diabetes/what-is-diabetes/ https://www.diabetesaustralia.com.au/about-diabetes/myths-facts/ Listener Q References: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmrj.12556 https://www.sciencedirect.com/science/article/pii/S1053811920304298 https://www.sciencedirect.com/science/article/pii/S1474442202000741 https://www.hindawi.com/journals/prt/2011/864605/ https://content.iospress.com/articles/neurorehabilitation/nre1447 Books: The Brain that Changes Itself by Norman Doidge Hallucinations by Oliver Sacks Limbless Association Podcast referenced in Listener Q: https://podcasts.apple.com/au/podcast/phantom-limb-pain/id1552006252?i=1000517118053&fbclid=IwAR3BcybpBzrvsHxBUGvl6C3LsJGFCSiuzld-7mv2PrZGoIyq-B47vFZPTLs

In this episode, Drs Aideen Daly and Julia Fuchs join us to discuss the clinical trials for a new 'artificial pancreas' system. This system is designed to manage a type 1 diabetics blood sugar, by integrating a continuous glucose monitor, an app, as well as an insulin pump.We discuss:1) Some of the history of type 1 diabetics, and why diabetics need to inject insulin to regulate their blood glucose.2) Insights gained on from the trials about the system's efficacy3) The difference between a single hormone vs two hormone systemAideen and Julia are clinical researchers in the Hovorka group at the Wellcome-MRC Institute of Metabolic Science in Cambridge, which is focused on developing the artificial pancreas technology.

ResourcesUse of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy (liebertpub.com)Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here (liebertpub.com)Adaptive-learning model predictive control for complex physiological systems: Automated insulin delivery in diabetes (Annual Reviews in Control)Dr. Cinar on the Illinois Tech websiteDanatech.org

  Photo compliments of Pixabay Today, we’re talking about an interesting development in pediatric medicine that will likely revolutionize the management of  childhood onset diabetes, a disease also known as type I diabetes.  The advance is known as the “artificial pancreas”. It sounds like science fiction, but as you are about to see, it’s not and it’s almost here. Musical Intro  Detour Down Science Lane In order to understand this new “artificial pancreas” technology, we need to take a detour down science drive, and make sure your knowledge of glucose metabolism is up to speed. Glucose is what is known as a simple sugar because it is very easy for your child’s cells to burn for quick energy or to store as fat. Your child’s body has to keep their blood sugar in the “Goldie Locks” range in order to be in good health, with a blood glucose not too high and not too low. A high blood glucose will produce diabetes symptoms like excessive thirst, excessive urination, fatigue, and possibly even coma and death. Low blood glucose can be equally dangerous since your child’s brain almost exclusively uses glucose for energy. Without enough glucose in their blood, your child will first get sweaty and weak and, if low enough, then slump into a coma. As you can see, whether high or low glucose, it’s all bad. Insulin, a hormone made in your child’s pancreas, is the hormone most responsible for regulating the glucose system. In a non-diabetic child, insulin unlocks your child’s cells to get glucose into cells and therefore out of their bloodstream, thus lowering their blood glucose. When glucose is scarce, like during fasting at night, insulin levels are usually low. When glucose is plentiful like after a big meal, your child’s pancreas is busy making insulin to push that excess glucose into fat cells. So, you can see that your child’s pancreas, the place where insulin production is controlled, acts as the master regulator of your child’s very important blood glucose level.  And remember, a pancreas does this all automatically.   Now let’s consider what is happening in a child with childhood onset or type 1 diabetes. Unfortunately, in this condition, the pancreas cannot make adequate insulin in response to a meal since the cells that produce that insulin were destroyed by an autoimmune process when the child first became diabetic. A type 1 diabetic child has to control their own blood sugar by a combination of carefully measured food intake balanced with exercise and insulin injections. Balancing all this is very difficult as you might imagine. This is a continuous job, 24/7, year in and year out, for the rest of the diabetic child's life. No wonder so many teenage diabetics rebel and just refuse to manage their disease, often with horrible consequences as a result.         History of the Management of Type 1 Diabetes To understand just how big a leap the artificial pancreas is in the management of diabetes, it helps to know how it has been managed in the past. The treatment goal when helping a child with type 1 diabetes has always been the same, keep the child’s blood glucose in the narrow range that the child’s pancreas did before they got sick. In the early days of diabetes management, doctors did this by having children taste their urine to see if was sweet or salty. You see, normal urine is salty and diabetic urine has a sweet taste because some of the excess glucose in their blood has spilled over into their urine. When the child’s urine turned sweet, that meant they needed an insulin injection to lower their blood glucose. Next, came what was known as the sliding scale management method, measure the amount of sugar in the urine with as chemical reaction rather than with taste buds. Insulin administration was thus adjusted by the amount of glucose in the child’s urine. This offered a little more refinement than tasting urine but not much. In the past few decades,

The introduction of artificial pancreas has proved to be a boon for diabetic patients this medical device has the potential to improve the conditions of people infected with type one diabetes hence people must be aware of the working of artificial pancreas in order to utilize it for maximum health benefits.Source-ElectronicsForYou Magazine --- Support this podcast: https://anchor.fm/nirmit-verma/support

Who should be the first to receive a COVID-19 vaccine when one becomes available? Find out about this and more in today’s PV Roundup podcast.

Dr Sufyan Hussain and Dana Lewis discuss the ‘Do it yourself' (DIY) artificial pancreas system.  This podcast is published open access in Diabetes Therapy journal and is fully citeable. You can access the published commentary to go alongside this podcast through the Diabetes Therapy website and by using this link. All conflicts of interest can be found online. This podcast in intended for medical professionals only. 

Dr Sufyan Hussain and Dana Lewis continue their discussion about the Do It Yourself the artificial pancreas system (DIY APS). This podcast is published open access in Diabetes Therapy journal and is fully citeable. You can access the published commentary to go alongside this podcast through the Diabetes Therapy website and by using this link. All conflicts of interest can be found online. This podcast in intended for medical professionals only.

Resources from the episode:Beta Bionics: https://www.betabionics.com/OpenAPS.org: https://openaps.org/Looped Facebook Group: https://www.facebook.com/groups/TheLoopedGroup/LoopDocs: https://loopkit.github.io/loopdocs/DiaTribe: https://diatribe.org/Clinicaltrials.gov: https://clinicaltrials.gov/

Ayten Salahi is an eco-conscious registered dietitian in-training, a nutrition researcher, sustainable home chef, food activist, and founder of the newly-formed Planetary Health Collective. She is a co-founder for the Friedman Food Policy Action Council (FFPAC) and a Research Assistant for the Tufts/USAID Office of Food for Peace working on the Food Aid Quality Review (FAQR) REFINE project. After spending a cumulative decade in research on cellular neurobiology and clinical management of diabetes through an Artificial Pancreas system, Ayten has made the shift to dedicate her life to improve both health and planetary health through the art of cooking, the science of medical nutrition, and the impact of food policy.In this episode: The environment!Her Planetary Health Collective Facebook groupHuman Design – Ayten is a projector and she is supposed to wait for an invitation to do something; Colleen being a manifestorGrowing up eating culturally different food and wanted to have foods that other children are having – SpaghettiOs! How processed food was giving her skin issues Own health was reactive to the food that she was eating Cell pathways with alcohol and which cell pathways change with diet and anxiety and depression – how alcohol and processed foods are changing our chemistry in our body Not eating right and drinking every weekend- eczema came back, migraines that last for days, stress Being in the hospital – vomiting foam – couldn’t turn her neck Realizing that she needed to slow down, reset and take care of herself- 5 -6 yearlong healing process How processed food affects our body- and how processed food is made to make us want more!Ayurveda! - Changes doshas she couldn’t eat the same things as she could in LA when she moved to Boston What to eat, distribution of healthy food in this country is unexpectable People should not be going hungry – processed food and policy Policy – and how its flawed Sustainable food plate and what it looks like – Planetary Health Plate Tangent- Trying not to buy food in packaging and plastic bags Marine mammals being killed from our plastic waste – China not buying our recycling anymore Call your state representatives! Awareness to policy and lifestyle changes Doing the inner work with Sinicism – hope is a moral choiceHow much the food system effects the environment References:Website: www.planetaryhealthrd.com Facebook: www.facebook.com/groups/planetaryhealthcollective Instagram: @planetaryhealthrdDare you to move podcastInstagram: @dareyoutomove_podcast_

Sponsors Sentry– use the code “devchat” for two months free on Sentry’s small plan GitLab | Get 30% off tickets with the promo code: DEVCHATCOMMIT My Ruby Story CacheFly Panel Mark Ericksen Michael Ries Josh Adams Eric Oestrich Joined by Special Guest: Frank Hunleth Summary Frank Hunleth, co-author of Nerves, shares where Nerves came from and how it got started. The panel discusses the Nerves 1.5 release and the improvements in it. Frank introduces Nerves Hub and Michael Ries gives a little marketing spin to it, explaining what you can do with Nerves Hub and why you would want to use it. The panel discusses the funding model for Nerves. Frank introduces Elixir Circuit, which helps you find libraries for your devices. He introduces Mountrap, a library that helps to switch between ports and NIFs. Frank introduces Grisp, what it is and how it compares to Nerves. Frank introduces Vintage Net and how it will help your devices stay online. Michael shares his experience with Nerves and gives some tips to make getting started with Nerves easy. The panel encourages programmers to get into embedded systems and explains how it will change the way they view coding.  Links EMx 008: Nerves! with Frank Hunleth and Justin Schneck Actor Model  Lisp Flavoured Erlang   Nerves 1.5.0 released!  https://www.nerves-hub.org/  https://opencollective.com/nerves-project  ElixirConf 2018 - Keynote - Justin Schneck  https://github.com/nerves-hub  https://github.com/nerves-hub/nerves_key  NervesKey  Lonestar ElixirConf 2019 - Building a Smart Sprinkler Controller with Nerves - Todd Resudek  https://elixir-circuits.github.io/  https://github.com/elixir-circuits/circuits_quickstart  https://github.com/fhunleth/muontrap  15 Ports and Port Drivers  GRiSP 2: DIVING DEEPER INTO EMBEDDED SYSTEMS  GRiSP 2  https://www.gigcityelixir.com/  https://hex.pm/packages/blinkchain  https://github.com/fhunleth/vintage_net  https://twitter.com/smartlogic/status/1161982882036015104  https://twitter.com/fhunleth?lang=en https://www.facebook.com/Elixir-Mix https://twitter.com/elixir_mix Picks Mark Ericksen: Boundaries  Michael Ries: ElixirConf 2015 - Embedded Elixir in Action by Garth Hitchens  ElixirConf 2017 - Building an Artificial Pancreas with Elixir and Nerves - Tim Mecklem  Jon Carstens: Dadgineering with Elixir+Nerves  2 Watt Solar Charger Kit  Josh Adams: 2017 National Electrical Code  Eric Oestrich: Parsely  The Big Elixir  Frank Hunleth: Power Control  https://hex.pm/packages/power_control Programming Boot Sector Games

Sponsors Sentry– use the code “devchat” for two months free on Sentry’s small plan GitLab | Get 30% off tickets with the promo code: DEVCHATCOMMIT My Ruby Story CacheFly Panel Mark Ericksen Michael Ries Josh Adams Eric Oestrich Joined by Special Guest: Frank Hunleth Summary Frank Hunleth, co-author of Nerves, shares where Nerves came from and how it got started. The panel discusses the Nerves 1.5 release and the improvements in it. Frank introduces Nerves Hub and Michael Ries gives a little marketing spin to it, explaining what you can do with Nerves Hub and why you would want to use it. The panel discusses the funding model for Nerves. Frank introduces Elixir Circuit, which helps you find libraries for your devices. He introduces Mountrap, a library that helps to switch between ports and NIFs. Frank introduces Grisp, what it is and how it compares to Nerves. Frank introduces Vintage Net and how it will help your devices stay online. Michael shares his experience with Nerves and gives some tips to make getting started with Nerves easy. The panel encourages programmers to get into embedded systems and explains how it will change the way they view coding.  Links EMx 008: Nerves! with Frank Hunleth and Justin Schneck Actor Model  Lisp Flavoured Erlang   Nerves 1.5.0 released!  https://www.nerves-hub.org/  https://opencollective.com/nerves-project  ElixirConf 2018 - Keynote - Justin Schneck  https://github.com/nerves-hub  https://github.com/nerves-hub/nerves_key  NervesKey  Lonestar ElixirConf 2019 - Building a Smart Sprinkler Controller with Nerves - Todd Resudek  https://elixir-circuits.github.io/  https://github.com/elixir-circuits/circuits_quickstart  https://github.com/fhunleth/muontrap  15 Ports and Port Drivers  GRiSP 2: DIVING DEEPER INTO EMBEDDED SYSTEMS  GRiSP 2  https://www.gigcityelixir.com/  https://hex.pm/packages/blinkchain  https://github.com/fhunleth/vintage_net  https://twitter.com/smartlogic/status/1161982882036015104  https://twitter.com/fhunleth?lang=en https://www.facebook.com/Elixir-Mix https://twitter.com/elixir_mix Picks Mark Ericksen: Boundaries  Michael Ries: ElixirConf 2015 - Embedded Elixir in Action by Garth Hitchens  ElixirConf 2017 - Building an Artificial Pancreas with Elixir and Nerves - Tim Mecklem  Jon Carstens: Dadgineering with Elixir+Nerves  2 Watt Solar Charger Kit  Josh Adams: 2017 National Electrical Code  Eric Oestrich: Parsely  The Big Elixir  Frank Hunleth: Power Control  https://hex.pm/packages/power_control Programming Boot Sector Games

In the first "in-between-isode" of MedPage Today's new Podcast series, Anamnesis, two of our reporters -- Kristen Monaco and Elizabeth Hlavinka -- discuss some highlighted abstracts presented at the meeting. NEW ORLEANS -- At ENDO 2019, the annual meeting of The Endocrine Society, some of the spotlighted research included advancements in diabetes, obesity, thyroid treatments, and advancements in reproductive health. Episode produced by Kristen Monaco and Elizabeth Hlavinka Hosted and sound engineering by Greg Laub Music by Jason Asistores, MD aka flatfives.

When Dana Lewis was 14 years old, she was diagnosed with type 1 diabetes, and that's when her interest in the pancreas and how it functions in the body began. While there's technology like insulin pumps and continuous glucose monitors (CGM) that help people manage type 1 diabetes, Lewis quickly learned the drawbacks associated with the fact that these devices don't communicate with each other and are not automated; those dealing with type 1 diabetes still have to do a lot of work to manage their condition.    This compelled Lewis to leverage open source code so that she could access her glucose data in real time from her devices, build a set of predictive alarms that would alert her to impending events related to her glucose levels, and create an algorithm which would allow for her insulin pump and CGM to interoperate in a closed loop system and communicate with a phone or computer in order to tell her when she needed more or less insulin. Enjoying the relief from having access to this technology, Lewis wanted to share what she'd created with everyone who could benefit from it.   She joins the podcast today to discuss why this technological capability has not already been made available in the health care sector, the challenges inherent in the development and widespread implementation of this type of technology, the details behind how the closed-loop system works, the results of studies looking at the effectiveness of the system she's built, misconceptions about how insulin pumps work, how the technology has drastically improved her sleep, level of energy, and clinical outcomes, and much more.    Tune in for the full conversation and visit https://openaps.org/ to learn more.

What do you know about diabetes could make you think about this artificial pancreas. Shortly, it’s about a system of diabetes care.

What if an algorithm could be your doctor? Living with Type 1 diabetes usually means making a lot of medical decisions on your own, sometimes daily. In this episode of ‘Fixed That For You’, you’ll hear about a problem millions of sick people face daily. It’s the story of Dana Lewis, a young woman who got tired of managing her disease, and decided to replace biology with data by creating an artificial pancreas. The results? Life changing. 'Fixed That For You' is an original podcast from Segment. For more on the series go to fixedthatforyou.com. In this episode, Dana talks about the Open Artificial Pancreas System project — here’s where you can read more about #OpenAPS. Want to learn more about what continuous glucose monitoring is or how it works? Take a look at the CGM made by Dexcom. Additionally, please visit the American Diabetes Association to learn more about how to manage diabetes. Build something of your own with a Raspberry Pi. Lastly, check out Nightscout, the visualization app Dana mentioned in this episode.

Rachael's son Jasper has been in two artificial pancreas studies. Today she is on the show to share what they learned about the Beta Bionics and Medtronic AP devices.  Show notes for people who are Bold with Insulin > Find out more about the Dexcom CGM > Get an Omnipod Demo today  > Save 10 % on Realgood Foods, use JUICEBOX at checkout > Dancing4Diabetes.com A full list of our sponsors  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio and all Android devices The show is now available as an Alexa skill. My type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here. Thank you! Follow Scott on Social Media @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on iTunes. Thank you! Arden's Day and The Juicebox Podcast are not charitable organizations.

More than a million Americans suffer from Type 1 diabetes. The disease occurs when the pancreas mysteriously stops producing insulin, the hormone that converts food into energy. Modern medicine has been able to recreate insulin, but not the finely calibrated delivery mechanism of the pancreas. Now a group of like-minded do-it-yourselfers have gotten together on the internet and—working outside the purview of organized medicine—have figured out how to link a pump, glucose monitor and smartphone to simulate a functioning pancreas. The results have been spectacularly successful.

Omnipod President and COO makes her second visit to the podcast to talk about the future of your favorite tubeless insulin pump. Artificial Pancreas, new PDM, adhesive, Medicare and so much more. The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here. Thank you! Show notes for people who are Bold with Insulin Animas Welcome Program or call 1-888-6-GETPOD and tell them the Juicebox Podcast sent you. Subscribe to the podcast on iTunes today! Android users... The JBP is available on Google Play The Juicebox Podcast is now available on iHeartRadio My type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad Follow Scott on Social Media @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on iTunes. Thank you! Arden's Day and The Juicebox Podcast are not charitable organizations.

For more than a million Americans with Type 1 diabetes, managing their disease can be a lot of painful -- and dangerous -- guesswork. But now, a new piece of technology promises to automate insulin delivery, and its helping some sufferers sleep through the night for the first time in their lives. From With Good Reason, the Short Listen combines compelling interviews and short-form storytelling to bring you the best of each week's episode in under 5 minutes.

This week a look at enhancements for future humans: wearable robots, an artificial pancreas, and a replacement retina, as well as limb and head transplants. Plus, in the news, a new hope for global warming, a new therapy to halt MS, what a shock from an electric eel feels like, and how much alcohol remains in food after cooking... Like this podcast? Please help us by supporting the Naked Scientists

This week a look at enhancements for future humans: wearable robots, an artificial pancreas, and a replacement retina, as well as limb and head transplants. Plus, in the news, a new hope for global warming, a new therapy to halt MS, what a shock from an electric eel feels like, and how much alcohol remains in food after cooking... Like this podcast? Please help us by supporting the Naked Scientists

We talked with Tim Mecklem about building an artificial Pancreas with Elixir and Nerves to help those with Type 1 Diabetes who want to “loop” — a process which involves monitoring glucose levels, predicting where a person’s glucose levels are heading, then delivering insulin based on that prediction. Tim is a Developer at Gaslight in Cincinnati where he builds software solutions with Ruby and Elixir, and he’s a member of the Nerves Core team.

We talked with Tim Mecklem about building an artificial Pancreas with Elixir and Nerves to help those with Type 1 Diabetes who want to “loop” — a process which involves monitoring glucose levels, predicting where a person’s glucose levels are heading, then delivering insulin based on that prediction. Tim is a Developer at Gaslight in Cincinnati where he builds software solutions with Ruby and Elixir, and he’s a member of the Nerves Core team.

Dana Lewis has Type 1 diabetes, which means her pancreas doesn't make the insulin she needs to survive. So she built a new one. Dana is the founder of the Open Source Artificial Pancreas System, a computer system that hundreds of diabetes patients now use to automatically manage their condition. We tell Dana's story on this episode of the GeekWire Health Tech Podcast. Read more about our health and technology coverage at GeekWire.com. Thank you to our sponsor, Providence St. Joseph Health’s Digital and Innovation Group. Follow them at twitter.com/provinnovation.

Gadgets reviewed 1) Abstats: https://blog.cedars-sinai.edu/wearable-tech-gut-check/ http://engineering.ucla.edu/fda-approves-use-of-ucla-created-wearable-device-to-address-gastrointestinal-disorders/ http://gi-logic.com/products/abstats/abstats-faq/ 2) Ebb Insomnia http://www.sleepreviewmag.com/2017/06/sleep-specialists-introduced-ebb-therapeutics-drug-free-insomnia-therapy-sleep-2017/ https://ebbsleep.com/products/ebb-insomnia-therapy 3) Artificial Pancreas https://www.usatoday.com/story/tech/columnist/2017/05/02/first-artificial-pancreas-systems-coming-market/100704988/ http://www.ksat.com/digital-life-365/diabetes-awareness/artificial-pancreas-game-changer-for-type-1-diabetes-treatment https://www.hospimedica.com/critical-care/articles/294769671/hybrid-diabetes-system-acts-as-artificial-pancreas.html Welcome to TalkingMed, the podcast where we discuss current medical news. Contact: talkingmedpodcast@gmail.com Twitter: @TalkingMedPod Song credit: Night Owl by Broke For Free from the Free Music Archive, used under CCBY Attribution License, modified from the original. Disclaimer: The information presented on this podcast are our own personal views, opinions, and research on the subject matter and do not represent those of our institution or our department. Anything discussed on this podcast should not be considered medical advice. Please contact a professional if you have any medical concerns. All content found on TalkingMed, including text, images, audio, or other formats were created for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have learned it from TalkingMed. Under no circumstances shall Vivek, Stephen, TalkingMed, any guests or contributors to the podcast or blog, or any employees, associates, or affiliates of TalkingMed be responsible for damages arising from use of the podcast or blog. This podcast or blog should not be used in any legal capacity whatsoever, including but not limited to establishing “standard of care” in a legal sense or as a basis for expert witness testimony. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast or blog. You hereby acknowledge that nothing contained on TalkingMed shall constitute financial, investment, legal and/or other professional advice and that no professional relationship of any kind is created between you and the TalkingMed. You hereby agree that you shall not make any financial, investment, legal and/or other decision based in whole or in part on anything contained on TalkingMed. Nothing on TalkingMed or included as a part of TalkingMed should be construed as an attempt to offer or render a medical opinion or otherwise engage in the practice of medicine. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.  The content may contain health- or medical-related materials or discussions regarding sexually explicit disease states. If you find these materials offensive, you may not want to use this content.

Tom Brobson is JDRF's National Director of Research Investment Opportunities. He was diagnosed with type 1 as an adult and has been involved personally in many artificial pancreas trials, the first of which had him hooked up to a computer in the hospital and not allowed to get up or go anywhere without a healthcare professional by his side. Of course, since then, the trials have included trials with equipment as small as a pump, CGM & smart phone. Stacey recorded Tom as he gave a presentation at a local JDRF walk kickoff event. He talks about stem cell research, the artificial pancreas project and other advances in diabetes technology. He also talks about approvals and access. In this episode, Stacey also talks about coughing for pain relief during shots and insertions. Really! We also share the adventures of people with T1D in the Arctic and in Alaska as this episode is released.  

The Type Zero Technologies artificial pancreas project is one of the many racing to market. Their technology comes from years of research, still ongoing, at the University of Virginia. This summer, they announced a new partnership with Tandem. Molly McElwee Malloy, who has type 1 herself, is the head of patient engagement for Type Zero. She talks about the studies, the progress and the emotional and mental side of artificial pancreas projects. Plus, necessity is the mother of invention and diabetes moms are nothing if not resourceful. In our Community Connection, the inventor of Diabetic Dabs talks about how she come up with this idea. Liz Sacco shares the story of how her son's diagnosis led her to find a why to clean up after finger sticks.  

This week, a conversation with some of the top executives at Animas, checking in on their newest products in development, the latest research and their company plans. Stacey talks to John Wilson, the Worldwide Vice President, Insulin Delivery for Johnson & Johnson and Krishna Venugopalan, the Worldwide Director of Research & Development, Insulin Delivery. They talk about Animas’s version of a hybrid closed loop, further Dexcom integration, remote capabilities and much more. Stacey also gives her take on all the talk around the "Artificial Pancreas" vs "Hybrid Closed Loop" language that came with the announcement that Medtronic received approval for a first of its kind device. And we mention the Diabetes Dance Dare, a new social media challenge from the American Diabetes Association.

Bigfoot Biomedical came on the scene in 2014 determined to change the way companies look at diabetes technology. They've moved forward quickly and are now starting their first clinical trial for their "Smartloop" automated insulin delivery system. Stacey talks to Bigfoot Chief Engineer Lane Desborough about what this system is, what the trial is testing, and how you can find out if you're eligible to enroll. Desborough is also the co-creator of Nightscout, the free, open source CGM remote monitoring system and is credited with coining the term "We are not waiting." Like all four founders of Bigfoot, Desborough has a child with type 1 diabetes.  

Today we have a study that shows us that tight blood glucose control in type 2 diabetes for a relatively concentrated amount of time can have positive effects that last for years when it comes to the eyes. Then, we’ll turn to the world of type 1 diabetes and some really interesting “real world” use by kids of a wearable artificial pancreas.

In this episode we take on the idea of data liberation. In particular we focus on medical data for this episode. Should the data stored in devices such as glucose monitors be available for you to use and not just view?  This Diabetes Activist Hacked Her Medical Device and Made an Artificial Pancreas: http://motherboard.vice.com/read/this-diabetes-activist-hacked-her-medical-device-and-made-an-artificial-pancreas

Scott Leibrand loves Dana Lewis (episode 63) and together they built Dana her very own artificial pancreas. This episode isn't a true part 2, it is more a different perspective on the story of OpenAPS then the one you heard in ep 63. In the end, I got the feeling that if this guy loves you... there is nothing that he wouldn't do. In episode 63 of the JBP I talk with Dana and get her perspective on their journey.  Show Notes Check out the all new MyOmniPod.com, like OmniPod on Facebook, follow them on Twitter and download their all new app for iOS or Android.  *** OpenAPS means basic overnight closed loop APS technology is more widely available to anyone with compatible medical devices who is willing to build their own system. Find out more at OpenAPS.org The JBP is now available on Google Play! Subscribe to the podcast on iTunes today! My type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad Follow Scott on Social Media @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.

Dana Lewis has type 1 diabetes and one day she decided to try to make the alarms louder on her Dexcom CGM. That simple endeavor led Dana and her husband Scott to build their very own artificial pancreas... then they shared the code that they wrote online. Dana says that anyone who wants to, can do the very same thing. This is a story about ingenuity, community and the desire to live a better life. In episode 64 of the JBP I talk with Scott and get his perspective on their journey.  Show Notes Check out the all new MyOmniPod.com, like OmniPod on Facebook, follow them on Twitter and download their all new app for iOS or Android.  *** OpenAPS means basic overnight closed loop APS technology is more widely available to anyone with compatible medical devices who is willing to build their own system. Find out more at OpenAPS.org The JBP is now available on Google Play! Subscribe to the podcast on iTunes today! My type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad Follow Scott on Social Media @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.

For people with type I diabetes, the day-to-day management of the disease can be a full-time job involving the monitoring blood glucose levels and injection of insulin. The medical device giant Medtronic has been working toward the development of what it's called an artificial pancreas, a steady improvement of pump and sensor technology to free type I diabetes patients and allow them to think less about the management of their disease. We spoke to Fran Kaufman, chief medical officer of Medtronic Diabetes, about the progress the company has made, its newest technology that is moving towards the market, and how close it is to realizing its vision of an artificial pancreas.

Former Denver Post Editor Greg Moore led The Denver Post at a tough time of circulation declines and employee layoffs -- but his tenure also included four Pulitzer Prizes. Then, two Fort Collins filmmakers followed Syrian refugees for the documentary "ALWADI: A Journey of Hope." And, diabetic kids went skiing to test out a new "artificial pancreas" that delivers insulin.

Scott sits with fellow Type 1 Diabetic Dana M. Lewis about the Open Artificial Pancreas System that she and her husband Scott Leibrand created. As other commercial entities race to "close the loop" for diabetics, how did two regular folks control diabetes with off-the-shelf parts? Dana demystifies the technology behind this software-managed diabetes solution.

Type 1 Diabetes is being diagnosed in children younger and younger these days. Hear about the very latest development in the war against diabetes – an ‘airbag’ that shuts insulin delivery off at night if levels get to high while a child is sleeping – and thereby preventing the patient from going into hypo glycemic shock, one of parents biggest fears

An hour long conversation with Insulet's Chief Commercial Officer Shacey Petrovic. Shacey answers questions from the diabetes community and from me in this candid chat. We talk about Medicare, Freestyle test strips, Artificial Pancreas, Omnipod/Dexcom partnership, new PDM status, the Forbes piece that paints Omnipod as being in jeopardy of being "out of the insulin pump market" in one year and much more.   Show Notes Learn more about OmniPod by visiting their website. Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad on Amazon. The Juicebox Podcast will soon be available on Google Play! Subscribe to the podcast on iTunes today! Check out my type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online   Follow Scott on Social Media On Twitter @ArdensDay @JuiceboxPodcast On Facebook Arden's Day - Juicebox Podcast On Instagram @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. ***** Freestyle Test Strip Info that Shacey spoke of... OmniPod® patients now have access to a dedicated toll-free Helpline if they should experience any co-pay or coverage issues with their FreeStyle® Test Strips (877-654-9975). Upon dialing this number, the patient will reach a knowledgeable customer support team member to help them navigate through their test strip coverage. As of November 2nd, patients who call the support number will also be offered the Prior Authorization Assistance Program (PAAP). The goal of the PAAP is to ensure easy access to FreeStyle test strips for new (and existing) OmniPod patients. With patient consent and HIPAA authorization, the following steps will be taken to execute on the PAAP:  1. Abbott will conduct a full Benefit Investigation.  2. From there, Abbott will both facilitate/assist in reaching out to the patient's payers and HCP to obtain the Prior Authorization (Appeal or Tier Exception) approval.  3. If approved, Abbott will be sending the PA approval and Rx referral to the patient's pharmacy of choice.  . If denied, Abbott will be driving patients to participating pharmacies (major retail chains). Eligible patients may be able to benefit/receive automatic and affordable co-pay savings at participating pharmacies.

Medtronic is the global leader in medical technology – alleviating pain, restoring health and extending the life for millions of people around the world. The Diabetes business at Medtronic (www.medtronicdiabetes.com) is the world leader in advanced diabetes management solutions, including integrated diabetes management systems, insulin pump therapy, continuous glucose monitoring systems and therapy management software, as well as world-class, 24/7 expert consumer and professional service and support. "Francine R. Kaufman, MD is Chief Medical Officer and Vice President of Global,Clinical and Health Affairs at Medtronic Diabetes. In addition to her role at Medtronic, Dr. Kaufman is a Distinguished Professor Emerita of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California, and an attending physician at Childrens Hospital Los Angeles. Dr. Kaufman has published more than 200 peer-reviewed and invited publications. She is the author of more than 30 books or book chapters."

Regulation of genetic testing kits is difficult, so how do we start to control this growing market? Christine Hauskeller, from the ESRC Centre for Genomics in Society at the University of Exeter, discusses her idea for an international standard which will help consumers make the right choices. Also this week, management of type 2 diabetes could be improved using an “artificial pancreas”. Roman Hovorka, principal research associate at the Institute of Metabolic Science, University of Cambridge, describes his new intelligent system for insulin delivery.

http://www.einstein.yu.edu - Jeffrey Pessin, Ph.D., discusses basic and clinical diabetes research being conducted at Einstein and Montefiore Medical Center, including the brain’s influence on appetite, autoimmune and stem cell therapies, and the efforts to develop an artificial pancreas. Dr. Pessin is director of Einstein’s Diabetes Research Center. This edition of Einstein On is hosted by Gordon Earle, associate dean for communications and public affairs.

Guest: Aaron Kowalski, PhD Host: Timothy Bailey, MD The artificial pancreas project lead by the Juvenile Diabetes Research Foundation has made tremendous progress towards eventual outpatient clinical studies. A recent panel of experts met with the FDA and NIH to determine appropriate guidelines. What are regulatory guidelines for the artificial pancreas project? Join guest host Dr. Timothy Bailey and his guest, Assistant Vice President and Director of Glucose Control Research at the Juvenile Diabetes Research Foundation, Dr. Aaron Kowalski as they discuss developments from controlled inpatient settings to real-world conditions and the need for regulation.

Guest: Aaron Kowalski, PhD Host: Steven Edelman, MD The Artificial Pancreas Project under the auspices of the Juvenile Diabetes Research Foundation is making strides towards closing the loop with improvements in communication between glucose sensors and external insulin pumps. What progress has been made in closing the loop in the development of the artificial pancreas? Join host Dr. Steven Edelman and his guest, director of glucose control research at JDRF, Dr. Aaron Kowalski, as they discuss current systems and future development of the artificial pancreas.

Guest: Bruce Buckingham, MD Host: Steven Edelman, MD The developing artificial pancreas carries tremendous potential for the treatment of diabetes. What is research telling us about the various steps to the implementation of the system? Join host Dr. Steven Edelman and his guest, pediatric endocrinologist and professor of medicine at Stanford University, Dr. Bruce Buckingham, as they discuss design, function, implementation, and obstacles to developing the artificial pancreas.

In Episode 6 of Living With Diabetes I welcome Pediatric Endocrinologist Dr. Ernest Post. He has years of experience working with younger diabetics living with Diabetes. We will talk about what he thinks diabetes treatments will look like in the future. Also we discuss the Artificial Pancreas. So check it out now! Episode Links Camp […]

Guest: William V. Tamborlane, MD Host: Bill Rutenberg, MD In this segment Dr. William Tamborlane discusses the management of type 1 diabetes using an artificial pancreas.